PATENT CLAIM ANALYSIS

Application Number: 15775716
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "274000"]

Abstract:
The invention relates to 4-(4-Cyano-2-thioaryl)dihydropyrimidinones of the formula (I) known from WO 2009/080199(A1) for use in a method for the treatment and/or recurrence rate reduction of a chronic wound selected from different types of ulcers and a chronic wound associated with Behçet's disease wherein the compound of the formula (I) is administered orally and wherein the treatment and/or reduction of recurrence rate of the chronic wound causes one or more of the effects selected from an increased wound closure rate, a reduced wound size, a shorter time to wound closure, an increase of the reepithelialisation of the chronic wound, an increase of the deposition of extracellular matrix such as collagen in the chronic wound, and a reduction of pain related to the chronic wound. The invention further relates to compounds of the formula (I) for use in a method for the treatment of neutrophilic dermatoses or for use in a method for the treatment of autoimmune blistering dermatoses.

Claim (Index 8):
Compound of the formula (I) as defined in any of  claims 1  and  4  to  7  for use in the method according to any of  claims 1  to  3 , wherein the compound of formula (I) is administered either alone or in addition to one or more of the physical, biological, topical and/or systemic wound management therapies selected from the group consisting of topical wound dressings, topical antiseptics, wound excision or debridement, weight reduction, appropriate footwear for an offloading effect, PDGF (Regranex), hyperbaric oxygen therapy, compression therapy wound therapy with negative pressure, maggot debridement therapy, and therapy with systemic antibiotics, wherein the physical and/or topical wound management therapies are employed simultaneously, sequentially or separately to administering of the compound of formula (I).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 2.38667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14522510', '12357821', '15205689', '10322068', '15106284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7622930372403804
- 35 USC 102 Novelty (BERT): 0.4960535563526033
- Combined Prediction Score: 0.7356690891516028
- Mean Citation Score: 149.45419399999997
- Max Citation Score: 155.61389
- Similarity Product: 95.74370766265037

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test